Corgenix announces establishment of bio-terrorism defense development program
In commenting about this new initiative in bio-terrorism defense diagnostics, Douglass Simpson, Corgenix President said, "This is a logical growth opportunity for Corgenix in a critical area that needs to be addressed on a national and international level. Bio-Terrorism Defense is a very important issue in this day and age, and we are confident that our collaboration with key industry and academic scientists will show meaningful results in a short period of time. We expect to present our program to the CDC, U.S. Department of Defense, and U.S. Department of Homeland Security, among other important government agencies and interested parties."
Most read news
Topics
Organizations
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.